Common mutations in the fibroblast growth factor receptor 3 (FGFR 3) gene account for achondroplasia, hypochondroplasia, and thanatophoric dwarfism
- PMID: 8723101
- DOI: 10.1002/(SICI)1096-8628(19960503)63:1<148::AID-AJMG26>3.0.CO;2-N
Common mutations in the fibroblast growth factor receptor 3 (FGFR 3) gene account for achondroplasia, hypochondroplasia, and thanatophoric dwarfism
Abstract
The mapping of the achondroplasia locus to the short arm of chromosome 4 and the subsequent identification of a recurrent missense mutation (G380R) in the fibroblast growth factor receptor 3 (FGFR-3) gene has been followed by the detection of common FGFR-3 mutations in two clinically related disorders: thanatophoric dwarfism (types I and II) and hypochondroplasia. The relative clinical homogeneity of achondroplasia was substantiated by demonstration of its genetic homogeneity as more than 98% of all patients hitherto reported exhibit mutations in the transmembrane receptor domain. Although most hypochondroplasia cases were accounted for by a recurrent missense substitution (N540K) in the first tyrosine kinase (TK 1) domain of the receptor, a significant proportion (40%) of our patients did not harbor the N540K mutation and three hypochondroplasia families were not linked to the FGFR-3 locus, thus supporting clinical heterogeneity of this condition. In thanatophoric dwarfism (TD), a recurrent FGFR-3 mutation located in the second tyrosine kinase (TK 2) domain of the receptor was originally detected in 100% of TD II cases, our series seven distinct mutations in three different protein domains were identified in 25 of 26 TD I patients, suggesting that TD, like achondroplasia, is a genetically homogenous skeletal disorder.
Similar articles
-
Common mutations in the gene encoding fibroblast growth factor receptor 3 account for achondroplasia, hypochondroplasia and thanatophoric dysplasia.Acta Paediatr Suppl. 1996 Oct;417:33-8. doi: 10.1111/j.1651-2227.1996.tb14291.x. Acta Paediatr Suppl. 1996. PMID: 9055906
-
Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia.Nat Genet. 1996 Jun;13(2):233-7. doi: 10.1038/ng0696-233. Nat Genet. 1996. PMID: 8640234
-
A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia.Nat Genet. 1995 Jul;10(3):357-9. doi: 10.1038/ng0795-357. Nat Genet. 1995. PMID: 7670477
-
Achondroplasia, hypochondroplasia and thanatophoric dysplasia: clinically related skeletal dysplasias that are also related at the molecular level.Int J Oral Maxillofac Surg. 1998 Dec;27(6):451-5. doi: 10.1016/s0901-5027(98)80036-2. Int J Oral Maxillofac Surg. 1998. PMID: 9869286 Review.
-
[From gene to disease; achondroplasia and other skeletal dysplasias due to an activating mutation in the fibroblast growth factor].Ned Tijdschr Geneeskd. 2001 Jun 2;145(22):1056-9. Ned Tijdschr Geneeskd. 2001. PMID: 11414167 Review. Dutch.
Cited by
-
Fibroblast Growth Factors and Cellular Communication Network Factors: Intimate Interplay by the Founding Members in Cartilage.Int J Mol Sci. 2022 Aug 2;23(15):8592. doi: 10.3390/ijms23158592. Int J Mol Sci. 2022. PMID: 35955724 Free PMC article. Review.
-
Signaling Pathways in Bone Development and Their Related Skeletal Dysplasia.Int J Mol Sci. 2021 Apr 21;22(9):4321. doi: 10.3390/ijms22094321. Int J Mol Sci. 2021. PMID: 33919228 Free PMC article. Review.
-
FGFR3 in Periosteal Cells Drives Cartilage-to-Bone Transformation in Bone Repair.Stem Cell Reports. 2020 Oct 13;15(4):955-967. doi: 10.1016/j.stemcr.2020.08.005. Epub 2020 Sep 10. Stem Cell Reports. 2020. PMID: 32916123 Free PMC article.
-
Severe achondroplasia due to two de novo variants in the transmembrane domain of FGFR3 on the same allele: A case report.Mol Genet Genomic Med. 2020 Mar;8(3):e1148. doi: 10.1002/mgg3.1148. Epub 2020 Jan 23. Mol Genet Genomic Med. 2020. PMID: 31975530 Free PMC article.
-
A framework for the radiologic diagnosis of skeletal dysplasias and syndromes as revealed by molecular genetics.Pediatr Radiol. 2019 Nov;49(12):1576-1586. doi: 10.1007/s00247-019-04545-8. Epub 2019 Nov 4. Pediatr Radiol. 2019. PMID: 31686164 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources